期刊文献+

老年肿瘤患者化疗风险评估 被引量:13

Chemotherapy Risk Assessment for Elderly Patients
下载PDF
导出
摘要 老年患者在恶性肿瘤患者中占很大比例,而大多数老年肿瘤患者都会进行化疗,化疗的不良反应在老年患者中也更为常见。因此,预测老年肿瘤患者的化疗不良反应非常重要,本文总结了预测老年肿瘤患者化疗不良反应的新型评估工具。 The incidence of cancer increases with age and most elderly patients wilt choose chemothera- py, and the complications of cytotoxic chemotherapy will be more common in these patients. Therefore, it is par- ticularly important to predict the chemotherapy toxicity for the elderly patients. This review article summarizes the recent chemotherapy risk assessment tools for the elderly patients.
机构地区 中国医学科学院
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2014年第5期551-555,共5页 Acta Academiae Medicinae Sinicae
关键词 老年患者 恶性肿瘤 化疗 不良反应 评估 elderly patients malignancy chemotherapy adverse reaction assessment
  • 相关文献

参考文献23

  • 1Smith BD, Smith GL, Hurria A, et al. Future of cancer in- cidence in the United States: burdens upon an aging, chan- ging nation [J]. J Clin Oncol, 2009, 27(17) :2758-2765.
  • 2Hurria A, Togawa K, Mohile SG, et al. Predicting chemo- therapy toxicity in older adults with cancer: a prospective multicenter study [J]. J Clin Oncol, 2011, 29 (25): 3457-3465.
  • 3Chrischilles EA, Pendergast JF, Kahn KL, et al. Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer I J]. J Clin Oncol, 2010, 28 (4) :620-627.
  • 4Mancini I, Bruera E. Constipation in advanced cancer pa- tients [J]. Support Care Cancer, 1998, 6(4) :356-364.
  • 5Zinzani PL, Storti S, Zaccaria A, et al. Elderly aggressive- histology non-Hodgkin' s lymphoma : first-line VNCOP-B reg- imen experience on 350 patients [ J ]. Blood, 1999, 94 ( 1 ) :33-38.
  • 6Crivellari D, Bonetti M, Castiglione-Gertsch M, et al. Bur- dens and benefits of adjuvant cyclophosphamide, methotrex- ate and fluorouracil and tamoxifen for elderly patients with breast Cancer: the International Breast Cancer Study Group trial V [J]. J Clin Oncol, 2000, 18(7) :1412-1422.
  • 7Feliu J, L6pez G6mez L, Madrofial C, et al. Gemeitabine plus vinorelbine in non-small cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin [J]. Cancer, 1999, 86(8) :1463-1469.
  • 8Kuderer NM, Cosler L, Crawford J, et al. Mortality and e- conomic impact of hospitalization with febrile neutropenia in patients with breast cancer: analysis of a nationwide database [J]. Proc Am Soc Clin Oncol, 2003, 22:27.
  • 9Balducci L, Corcoran MB. Antineoplastic chemotherapy of the older cancer patient [ J]. Hematol Oncol Clin North Am, 2000, 14(1) :193-212.
  • 10Jacobson SD, Cha S, Sargent DJ, et al. Tolerability, dose intensity and benefit of 5FU based chemotherapy for advanced colorectal cancer (CRC) in the elderly: a North Central Cancer Treatment Group study [ J ]. Proc Am Soc Clin On- col, 2001, 20:587.

同被引文献116

引证文献13

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部